Literature DB >> 23273646

Serum total cholesterol: a mortality predictor in elderly hospitalized patients.

Avraham Weiss1, Yichayaou Beloosesky, Hemda Schmilovitz-Weiss, Ehud Grossman, Mona Boaz.   

Abstract

BACKGROUND & AIMS: Elevated serum total cholesterol levels are associated with increased risk of cardiovascular mortality among middle aged adults, but not the elderly. We therefore examined whether increased serum total cholesterol reduces mortality risk in the hospitalized elderly.
METHODS: Of 1852 patients consecutively admitted to an acute geriatric department from 1/1/99-12/31/00, only 298 (49.6% males, mean age 81.36 ± 6.3 years) who had measured serum total cholesterol and albumin levels were included in the study and followed until August 31, 2004. Mortality data were extracted from their death certificates.
RESULTS: During follow-up of 3.47 ± 1.87 years, 248 patients died. These patients had significantly lower levels of baseline serum total cholesterol (183.3 ± 45.4 vs. 200.2 ± 37.9, p = 0.01) and albumin (3.6 ± 0.5 vs. 3.8 ± 0.3 g/l, p = 0.002) than the survivors. In the Cox regression analysis, serum total cholesterol emerged as a significant, independent predictor of mortality in this cohort. Specifically, each 1 mg/dl increase in serum total cholesterol reduced risk of death by 0.4%. This association persisted even after controlling for serum creatinine, age, body mass index, dementia and congestive heart failure. These factors were also significantly, independently associated with mortality.
CONCLUSION: In very elderly hospitalized subjects, increased levels of serum total cholesterol and albumin may be associated with reduced mortality risk.
Copyright © 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273646     DOI: 10.1016/j.clnu.2012.11.012

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  Prognostic factors of long-term survival in geriatric inpatients. Should we change the recommendations for the oldest people?

Authors:  B Bień; K Bień-Barkowska; A Wojskowicz; A Kasiukiewicz; Z B Wojszel
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

2.  The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020.

Authors:  Otto Mayer; Jan Bruthans; Simona Bilkova; Jitka Seidlerova; Josef Jirak; Jan Filipovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-04-20       Impact factor: 1.648

3.  Serum total cholesterol concentration and 10-year mortality in an 85-year-old population.

Authors:  Yutaka Takata; Toshihiro Ansai; Inho Soh; Shuji Awano; Ikuo Nakamichi; Sumio Akifusa; Kenichi Goto; Akihiro Yoshida; Hiroki Fujii; Ritsuko Fujisawa; Kazuo Sonoki
Journal:  Clin Interv Aging       Date:  2014-02-13       Impact factor: 4.458

Review 4.  Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.

Authors:  Matthew M Y Lee; Naveed Sattar; John J V McMurray; Chris J Packard
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

5.  Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.

Authors:  Seung Hee Kim; Ki Young Son
Journal:  Lipids Health Dis       Date:  2021-01-06       Impact factor: 3.876

6.  High Levels of Low-Density Lipoproteins Correlate with Improved Survival in Patients with Squamous Cell Carcinoma of the Head and Neck.

Authors:  Torben Wilms; Linda Boldrup; Xiaolian Gu; Philip J Coates; Nicola Sgaramella; Karin Nylander
Journal:  Biomedicines       Date:  2021-05-04

7.  Association of Cardiovascular Risk Factors and APOE Polymorphism with Mortality in the Oldest Old: A 21-Year Cohort Study.

Authors:  Lilian Vivian; Neide Maria Bruscato; Berenice Maria Werle; Waldemar de Carli; Renata Alonso Gadi Soares; Paulo Caleb de Lima Santos Júnior; Emilio Hideyuki Moriguchi
Journal:  Arq Bras Cardiol       Date:  2020-11       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.